These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 1980316)
1. Use of LeuM1 monoclonal antibody for the diagnosis of Hodgkin's disease. Memon GM; Alam SM J Pak Med Assoc; 1990 Jul; 40(7):156-9. PubMed ID: 1980316 [TBL] [Abstract][Full Text] [Related]
2. Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues. Pinkus GS; Thomas P; Said JW Am J Pathol; 1985 May; 119(2):244-52. PubMed ID: 3887932 [TBL] [Abstract][Full Text] [Related]
3. Morphological and immunohistochemical investigation of non-Hodgkin's lymphoma combined with Hodgkin's disease. Hansmann ML; Fellbaum C; Hui PK; Lennert K Histopathology; 1989 Jul; 15(1):35-48. PubMed ID: 2548946 [TBL] [Abstract][Full Text] [Related]
4. Characterization of Reed-Sternberg cells with granulocyte specific monoclonal antibody. Memon GM; Alam SM J Pak Med Assoc; 1993 Feb; 43(2):32-4. PubMed ID: 8497101 [TBL] [Abstract][Full Text] [Related]
5. Utility of combining antigranulocyte with antileukocyte antibodies in differentiating Hodgkin's disease from non-Hodgkin's lymphoma. Medeiros LJ; Weiss LM; Warnke RA; Dorfman RF Cancer; 1988 Dec; 62(12):2475-81. PubMed ID: 2973368 [TBL] [Abstract][Full Text] [Related]
6. Bauhinia purpurea--a new paraffin section marker for Reed-Sternberg cells of Hodgkin's disease. A comparison with Leu-M1 (CD15), LN2 (CD74), peanut agglutinin, and Ber-H2 (CD30). Sarker AB; Akagi T; Jeon HJ; Miyake K; Murakami I; Yoshino T; Takahashi K; Nose S Am J Pathol; 1992 Jul; 141(1):19-23. PubMed ID: 1352944 [TBL] [Abstract][Full Text] [Related]
7. Inflammatory malignant fibrous histiocytoma: distinction from Hodgkin's disease and non-Hodgkin's lymphoma by a panel of leukocyte markers. Khalidi HS; Singleton TP; Weiss SW Mod Pathol; 1997 May; 10(5):438-42. PubMed ID: 9160307 [TBL] [Abstract][Full Text] [Related]
8. Granulocyte and HLA-D region specific monoclonal antibodies in the diagnosis of Hodgkin's disease. Norton AJ; Isaacson PG J Clin Pathol; 1985 Nov; 38(11):1241-6. PubMed ID: 3864794 [TBL] [Abstract][Full Text] [Related]
9. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas. Miettinen M Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642 [TBL] [Abstract][Full Text] [Related]
10. Paraffin section immunohistochemistry. II. Hodgkin's disease and large cell anaplastic (Ki1) lymphoma. Hall PA; d'Ardenne AJ; Stansfeld AG Histopathology; 1988 Aug; 13(2):161-9. PubMed ID: 3169684 [TBL] [Abstract][Full Text] [Related]
11. An evaluation of the utility of anti-granulocyte and anti-leukocyte monoclonal antibodies in the diagnosis of Hodgkin's disease. Dorfman RF; Gatter KC; Pulford KA; Mason DY Am J Pathol; 1986 Jun; 123(3):508-19. PubMed ID: 3717303 [TBL] [Abstract][Full Text] [Related]
12. Anti-BLA.36 monoclonal antibody shows reactivity with Hodgkin's cells and B lymphocytes in frozen and paraffin-embedded tissues. Della Croce DR; Imam A; Brynes RK; Nathwani BN; Taylor CR Hematol Oncol; 1991; 9(2):103-14. PubMed ID: 1869241 [TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies in the diagnosis of Hodgkin's disease. The search for a rational panel. Chittal SM; Caverivière P; Schwarting R; Gerdes J; Al Saati T; Rigal-Huguet F; Stein H; Delsol G Am J Surg Pathol; 1988 Jan; 12(1):9-21. PubMed ID: 2827535 [TBL] [Abstract][Full Text] [Related]
14. Usefulness of K-1 (CD-30) marker in Hodgkin's disease. Shakoor KA; Saleh A; Khanzada MS J Pak Med Assoc; 2002 Oct; 52(10):442-7. PubMed ID: 12553671 [TBL] [Abstract][Full Text] [Related]
15. Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker. Pinkus GS; Said JW Am J Pathol; 1988 Nov; 133(2):211-7. PubMed ID: 3263805 [TBL] [Abstract][Full Text] [Related]
16. Coexpression of CD15 and CD20 by Reed-Sternberg cells in Hodgkin's disease. Zukerberg LR; Collins AB; Ferry JA; Harris NL Am J Pathol; 1991 Sep; 139(3):475-83. PubMed ID: 1716042 [TBL] [Abstract][Full Text] [Related]
17. The Lewis X antigen. A new paraffin section marker for Reed-Sternberg cells. Ree HJ; Teplitz C; Khan A Cancer; 1991 Mar; 67(5):1338-46. PubMed ID: 1703918 [TBL] [Abstract][Full Text] [Related]
18. Is fascin really a useful marker in distinguishing between classical Hodgkin's lymphoma and various types of non-Hodgkin's lymphomas in difficult cases? Idrees R; Ahmad Z; Qureshi A; Ahsan A; Pervez S J Clin Pathol; 2010 Jul; 63(7):571-4. PubMed ID: 20591908 [TBL] [Abstract][Full Text] [Related]
19. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation? Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemistry of Hodgkin and non-Hodgkin lymphomas with emphasis on the diagnostic significance of the BNH9 antibody reactivity with anaplastic large cell (CD30 positive) lymphomas. Carbone A; Gloghini A; Volpe R Cancer; 1992 Dec; 70(11):2691-8. PubMed ID: 1330287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]